作者
Atalel Fentahun Awedew, Hannah Han, Behzad Abbasi, Mohsen Abbasi-Kangevari, Muktar Beshir Ahmed, Omar Almidani, Erfan Amini, Jalal Arabloo, Ayele Mamo Argaw, Seyyed Shamsadin Athari, Daniel Atlaw, Maciej Banach, Amadou Barrow, Akshaya Srikanth Bhagavathula, Vijayalakshmi S Bhojaraja, Boris Bikbov, Belay Boda Abule Bodicha, Nadeem Shafique Butt, Florentino Luciano Caetano dos Santos, Omid Dadras, Xiaochen Dai, Linh Phuong Doan, Sahar Eftekharzadeh, Ali Fatehizadeh, Tushar Garg, Teferi Gebru Gebremeskel, Motuma Erena Getachew, Seyyed-Hadi Ghamari, Syed Amir Gilani, Mahaveer Golechha, Veer Bala Gupta, Vivek Kumar Gupta, Simon I Hay, Mohammad-Salar Hosseini, Mehdi Hosseinzadeh, Ayesha Humayun, Irena M Ilic, Milena D Ilic, Nahlah Elkudssiah Ismail, Mihajlo Jakovljevic, Shubha Jayaram, Seyed Behzad Jazayeri, Alelign Tasew Jema, Ali Kabir, Ibraheem M Karaye, Yousef Saleh Khader, Ejaz Ahmad Khan, Iván Landires, Sang-woong Lee, Shaun Wen Huey Lee, Stephen S Lim, Stany W Lobo, Azeem Majeed, Mohammad-Reza Malekpour, Narges Malih, Ahmad Azam Malik, Entezar Mehrabi Nasab, Tomislav Mestrovic, Irmina Maria Michalek, Gedefaye Nibret Mihrtie, Mohammad Mirza-Aghazadeh-Attari, Awoke Temesgen Misganaw, Ali H Mokdad, Mariam Molokhia, Christopher JL Murray, Sreenivas Narasimha Swamy, Son Hoang Nguyen, Ali Nowroozi, Virginia Nuñez-Samudio, Mayowa O Owolabi, Shrikant Pawar, Norberto Perico, David Laith Rawaf, Salman Rawaf, Reza Rawassizadeh, Giuseppe Remuzzi, Amirhossein Sahebkar, Chethan Sampath, Jeevan K Shetty, Migbar Mekonnen Sibhat, Jasvinder A Singh, Ker-Kan Tan, Gebremaryam Temesgen, Musliu Adetola Tolani, Marcos Roberto Tovani-Palone, Sahel Valadan Tahbaz, Rohollah Valizadeh, Bay Vo, Linh Gia Vu, Lin Yang, Fereshteh Yazdanpanah, Arzu Yigit, Vahit Yiğit, Ismaeel Yunusa, Mazyar Zahir, Theo Vos, M Ashworth Dirac
发表日期
2022/11/1
期刊
The Lancet Healthy Longevity
卷号
3
期号
11
页码范围
e754-e776
出版商
Elsevier
简介
Background
Benign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted life-years (DALYs) due to benign prostatic hyperplasia, in 21 regions and 204 countries and territories from 2000 to 2019.
Methods
This study was conducted with GBD 2019 analytical and modelling strategies. Primary prevalence data came from claims from three countries and from hospital inpatient encounters from 45 locations. A Bayesian meta-regression modelling tool, DisMod-MR version 2.1, was used to estimate the age-specific, location-specific, and year-specific prevalence of …
学术搜索中的文章
AF Awedew, H Han, B Abbasi, M Abbasi-Kangevari… - The Lancet Healthy Longevity, 2022